Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.
W l
Wl
McGuire
J S
JS
Meyer
B
B
Barlogie
T E
TE
Kute
D000704:Analysis of Variance; D000782:Aneuploidy; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology*; D001973:Bromodeoxyuridine / Q000378:metabolism; D018288:Carcinoma, Small Cell / Q000473:pathology; D002453:Cell Cycle; D002460:Cell Line; D004247:DNA / Q000032:analysis; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007399:Interphase; D008175:Lung Neoplasms / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D009101:Multiple Myeloma / Q000473:pathology; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012313:RNA / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D013936:Thymidine / Q000378:metabolism
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D012313:RNA; D004247:DNA; D001973:Bromodeoxyuridine; D013936:Thymidine